KR20180118274A - Geonjo yuikkyun eul chungjeon ha n ilhoe yong yonggi - Google Patents

Abstract

Disclosed is technology for a disposable container filled with dry beneficial bacteria, capable of safely storing dry beneficial bacteria for a long time. According to the technology, the activity of beneficial bacteria is suppressed and the bacteria are stored safely for a long time, and then, if necessary, the bacteria are able to be properly injected into a required part of a human body. Moisture such as purified water or drink is supplied into the container to dilute the bacteria with a diluent, and then, the diluted bacteria solution is able to be conveniently injected into a human body through at least one among an eye, the nose, an ear, the anus, the urethra, and the vagina. During the injection procedure, the container does not cause pain, especially in the anus, and a user does not need to get some excrement on the hands.

Description

[0001] The present invention relates to a disposable container filled with dry beneficial bacteria,

The present invention relates to a disposable container filled with dry benefit bacteria. More specifically, a live bacteria useful in the body is filled in at least one disposable container selected from the group consisting of a syringe and a syringe, sealed and stored safely, A disposable container filled with dry and beneficial bacteria, which is prepared so as to be easily injected into the eyes, nose, ears, an urethra, urinary tract, female vagina, .

Beneficial bacteria such as yeast and lactobacillus which are useful in the body can be used for digestion, circulation, obesity suppression, improvement of brain function, delay of skin aging, prevention of cancer, antioxidant activity, improvement of constitution, growth promotion, fatty liver, hepatitis, hypertension, , It is produced in the form of pills, granules or beverages and is conveniently used for oral administration. However, since most of the beneficial bacteria are sterilized by gastric juice during digestion, Or by coating the wall with an anti-resistant substance as an encapsulated particle to overcome the death of beneficial bacteria from stomach acid.

However, the specific constitution in which gastric acid is over 20 times more abundant than that of the general public to dissolve antibiotics, alcohol, instant food, excessive stimulant foods, stress or even metal is killed by beneficial bacteria coated with anti-resistant capsules, There is a problem that it is very difficult to live and grow well.

In addition, even if proliferation is activated after reaching the large intestine by living alive through oral administration, beneficial bacteria are extinguished due to antibiotics, alcohol, instant food, overly irritating food, stress and others.

In order to solve this problem, it has become an alternative to maximize the survival rate in the large intestine by administering beneficial bacteria directly to the large intestine through the anus, rather than oral administration.

As part of the anal administration, suppository solid capsules can be used by filling the capsules designed to dissolve in the body's heat or water and dissolve the beneficial bacteria. However, when inserting a suppository solid capsule filled with the above-mentioned beneficial bacteria into the anus, it is difficult to insert into the large intestine by a strong anal sphincter. When the insomnia is inserted into the large intestine, There is a problem that mutations appear on the screen.

In addition, the diluted solution of beneficial bacteria can be administered orally by using an enema syringe. Even in this case, it is troublesome to select and design a beneficial microorganism suitable for a specific disease among various hundreds of various kinds of beneficial microorganisms based on the opinion of a specialist every time, and it is prepared and administered by a specialist, Therefore, the sensitive part such as the anal or genital area is a sensitive part in the body which is not to be exposed to the others including the specialist, and therefore, there is a problem in that it is necessary to take the mistreatment in the treatment.

Particularly, the diluted solution of the beneficial bacteria prepared by the expert in the above, or the culture solution thereof is not suitable for mass production because it is difficult to store safely for a long period of time by generating gas, acid, alcohol,

On the other hand, beneficial bacteria such as yeast and lactic acid bacteria, which are known as hundreds of species, have various functions such as production of antibacterial substance, inhibition of the activity of germs and removal of germs when applied to human body and are used for the improvement of treatment for constipation, atopy, However, oral administration is made.

Of course, in order to maximize the activity of beneficial bacteria, anal administration or vaginal administration is performed, but since it is directly prepared and applied by a specialist in the preparation of beneficial bacteria, it is applied only to a very small number of patients, And a method for applying it to mass production has been proposed.

Furthermore, in order to maximize the activity of the useful bacteria, it is a special case that the beneficial bacteria can be directly administered to the eyes, ears and nose. In this case, it is possible to prepare the beneficial bacteria directly by the specialist such as the anal administration or the vaginal administration of the female, but it is also necessary. It is troublesome to prepare useful bacteria. Most of these directly prepared foods are applied to the human body in a short time, which makes it difficult to safely store them for a long period of time.

In order to solve the above-mentioned problems, the present invention provides a method for safely storing beneficial bacteria in a container which is easy to administer to the eyes, nose, ear, urethra, anus, female vagina, etc., A diluent is diluted in a diluent, and the diluent is diluted in a diluent to be easily administered into the body.

The disposable container filled with the dry benefit bacteria according to an embodiment of the present invention is characterized by comprising at least one dry benefit bacteria selected from the group consisting of yeast and lactobacillus and a syringe container selected from the group consisting of a syringe container Wherein the disposable container is filled with 0.000001 to 80% of the inner volume of the disposable container, and the disposable container filled with the dry and beneficial bacteria has an inlet for receiving air and moisture from outside, Thereby inhibiting the activity of the beneficial microorganism, thereby enabling the dry beneficial microorganism to be safely stored for a long period of time.

In the examples, yeast as the above-mentioned dry beneficial bacteria is collectively referred to as purified yeast and purified and dried, for example; Shikaromisseserabissia, Toru-ryu, Shikoku caramisse pombe. Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp. Corynebacterium, Cryptobacillus, Candida albicans, Cryptobacillus, Cryptobacillus, Cryptobacillus, Cryptobacterium, Cryptobacillus, Cryptobacillus, Cryptobacillus, Kokkus Neoformans and Korean Ministry of Agriculture No.15-5 (Accession No .: KCTC12288BP) No 98-5 (Accession No .: KCCM11396P) No 113-8 (Accession No .: KCTC12289BP) No 157-1 (Accession No: KCTC1290BP), and the like.

In the examples, the lactic acid bacterium as the beneficial bacteria is also referred to as lactic acid bacterium and collectively refers to the fungal bacteria of the rear wall, for example; A lactobacillus bacterium, a lactobacillus bacterium, a lactobacillus bacterium, a lactobacillus strain, a lactobacillus acidophilus, a lactobacillus casei, a lactobacillus sacyllactobacillus sacyllactobacillus bulgaricus, a lactobacillus fermentum, a lactobacillus fulantarum, a lactobacillus lambothus, a lactobacillus salivarius, , Lactobacillus helveticus, Lactobacillus lutei), bifidobacteria (bifidobacterium bifidum, bifidobacterium longum, bifidobacterium, bifidobacterium infantis, bifidobacterium animalis lactis ), Streptococcus sp. (Streptococcus schizophyllus), and Bacela sp. (Weissella coriensis).

In an embodiment of the present invention, at least one selected from the group consisting of a nutrient, herbal medicine extract, powdered milk, sugar, starch, and flour is further added in an amount of 0.00001 to 50 parts by weight based on the total weight of the beneficial bacteria.

In an embodiment, the disposable container is at least one container selected from the group consisting of a syringe container and a syringe container which is easily injected into at least one of eyes, nose, ear, anus, urethra and female vagina in the body, The above-mentioned dry beneficial bacteria can be contained and filled in the inside of the container, and after the above-mentioned dry beneficial bacteria are filled, the inlet of the container is sealed to prevent the contact with the outside air and moisture to inhibit the activity of the beneficial bacteria. .

In an embodiment, the disposable container may contain helium gas, argon gas, nitrogen gas, carbon dioxide gas as an inert gas for container packaging in order to more safely prevent the bacteria from being activated by the air remaining in the container of dry benefit bacteria in the container And at least one selected from the group consisting of air and oxygen is added and filled.

The present invention is designed to suitably apply to a specific disease or specific site among a variety of beneficial bacteria, and the selected dry beneficial bacteria are standardized and filled and closed in a container to prevent contact with water to inhibit the activity of the beneficial bacteria and to safely store them for a long period of time So that it is possible to mass-produce and provide the advantage that it can be provided to consumers at a low cost.

In addition, the present invention is advantageous in that at least any one or more containers selected from a syringe container and a syringe container that are easy to insert into eyes, nose, ear, anus, urethra, female vagina in the body are filled with beneficial bacteria, As well as anal administration, as well as eyes, nose, ears, urethra, female vagina, etc., can be easily administered directly into the body. In particular, it does not cause pain during anal administration and is hygienic because it can be applied without stool on the hands of the handler.

FIG. 1 is a perspective view of a disposable syringe dispenser packed with dry benefit bacteria according to an embodiment of the present invention. FIG. 2 is a perspective view of a disposable syringe container according to the present invention, And Fig. 3 is a photograph showing an operation diagram for schematically illustrating an operation state for explaining the operation of Fig.
FIG. 4 is a perspective view of a disposable syringe container filled with another dry benefit bacterium according to an embodiment of the present invention. FIG. 5 is a front view of the disposable syringe container of FIG. FIG. 6 is a photograph showing an operation diagram for illustrating the operation of FIG. 4, schematically showing an operation state.

Specific structural and functional descriptions of the embodiments of the present invention disclosed herein are for illustrative purposes only and are not to be construed as limitations of the scope of the present invention. And should not be construed as limited to the embodiments set forth herein or in the application.

The embodiments according to the present invention can make various changes and have various forms, so that specific embodiments are described in detail in this specification or application. It should be understood, however, that the embodiments according to the concepts of the present invention are not intended to be limited to any particular mode of disclosure, but rather all variations, equivalents, and alternatives falling within the spirit and scope of the present invention.

Hereinafter, the disposable container filled with the dry benefit bacteria of the present invention will be described in detail with reference to the following examples.

Example 1.

Referring to FIGS. 1, 2 and 3, FIG. 1 is a perspective view of a disposable syringe dispenser packed with dry benefit bacteria according to an embodiment of the present invention. FIG. 2 is a perspective view of a disposable syringe container according to the present invention, And Fig. 3 is a photograph showing an operation diagram for schematically illustrating an operation state for explaining the operation of Fig.

First, as shown in Fig. 1 and Fig. 2, the dry, The packaged disposable syringe dispenser (100) comprises at least one dry benefit bacteria (10) selected from the group consisting of yeast and lactic acid bacteria, and a disposable syringe container (20) sealed after being filled with the dry benefit bacteria, 10) is filled with 0.000001 to 80% of the inner volume of the disposable syringe container (20). The disposable syringe container (20) filled with the dry bacteria is sealed so that the contact with the outside air and moisture is blocked Thereby inhibiting the activity of the beneficial microorganism, thereby enabling the dry beneficial microorganism to be safely stored for a long period of time.

In the present invention, the dry and beneficial microorganism (10) is useful for the treatment or amelioration of a specific disease, moisturizing, or the like when applied to at least one part of the eye, nose, ear, anus, urethra, It is not limited as long as it is usable, and it is preferable that it belongs to yeast or lactic acid bacteria group.

The yeast as the dry profitable bacterium (10), the yeast as the dry profitable bacterium (10), the yeast is a kind of fungus as a eukaryotic cell and usually belongs to the genus Saccharomyces (= sugar fungus) For example; Shikaromisseserabissia, Toru-ryu, Shikoku caramisse pombe. Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp. Corynebacterium, Cryptobacillus, Candida albicans, Cryptobacillus, Cryptobacillus, Cryptobacillus, Cryptobacterium, Cryptobacillus, Cryptobacillus, Cryptobacillus, Kokkus Neoformans and Korean Ministry of Agriculture No.15-5 (Accession No .: KCTC12288BP) No 98-5 (Accession No .: KCCM11396P) No 113-8 (Accession No .: KCTC12289BP) No 157-1 (Accession No: KCTC1290BP), and the like. Examples of the brewing yeast include top-side fermentation yeast, bottom-side fermentation yeast, acid membrane yeast, and fly ash yeast.

In the present invention, lactic acid bacteria as lactic acid bacteria (10) are also referred to as lactic acid bacteria and collectively referred to as fungal bacteria of the rear wall. A lactobacillus bacterium, a lactobacillus bacterium, a lactobacillus bacterium, a lactobacillus strain, a lactobacillus acidophilus, a lactobacillus casei, a lactobacillus sacyllactobacillus sacyllactobacillus bulgaricus, a lactobacillus fermentum, a lactobacillus fulantarum, a lactobacillus lambothus, a lactobacillus salivarius, , Lactobacillus helveticus, Lactobacillus ruteri, Lactobacillus ruteri), bifidobacteria (bifidobacterium bifidum, bifidobacterium longum, bifidobacterium, bifidobacterium infantis, bifidobacterium, (Streptococcus schizophyllus), and Bacela (Weissella coliensis). The present invention also provides a method for producing the same.

In the present invention, 0.00001 ~ 50 parts by weight of at least one member selected from the group consisting of nutrients, herbal medicine extracts, powdered milk, sugar, starch, and cereal powder may be further added to the dry benefit bacteria. However, these additives should be added so as not to interfere with the inhibition of the activity of the above-mentioned dry beneficial bacteria.

These additives are diluted with the moisture of the beneficial bacteria and become a food source at the time of proliferation, thereby increasing the activity force or adding a pharmacological effect to the body.

In the present invention, the moisture content of the nutrient, herbal medicine extract, powdered milk, sugar, starch, and flour, including dry and beneficial bacteria, is 14% or less, preferably 9% or less. If the moisture content is excessively higher than the above-mentioned range, the beneficial bacteria will multiply through moisture and thus become corrupted in a short period of time, making it difficult to safely store them for a long period of time.

The dry, beneficial microorganism can be designed to be administered differently according to a specific site and a specific disease in the body. As the species of the strain may be the same or different, or the content may be the same or in a similar ratio, Can be appropriately designed and suitably prepared (composition).

That is, the beneficial microorganism (10) of the present invention can be mass-produced by being designed to be standardized so as to be easily applied to specific diseases and specific sites in the body.

In case of anal administration, the constipation is at least one kind of lactic acid bacteria selected from Weissella koreensis 521, Lactobacillus sacae 171, Lactobacillus casei CBT LC5, Lactobacillus plantarum CBT LP3, Lactobacillus lambusaceus CBT LR5 They can be mixed / prepared in the same ratio.

In case of bacterial diarrhea in case of anal administration, lactic acid bacteria of Bifidobacterium anilmarlis lactis CBT BL3 can be selected and prepared.

In the case of atopic dermatitis in the case of anal administration, the amount of serum immunoglobulin IgE (antibody by constitution) is directly reduced. In the case of atopic dermatitis, Lactobacillus casei CBT known in a composition for prevention or treatment of atopy of Korean Registration No. 10-1724601 Dried lactobacillus such as Lactobacillus plantarum CBT LP3, Lactobacillus lambusaceus CBT LR5, and Bifidobacterium animalis lactis CBT BL3 can be mixed / prepared in an amount of 5 to 80 parts by weight based on the total weight ratio of the composition .

Further, in the mixed lactic acid bacteria, any one or more of Saccharomyces cerevisiae, Aspergillus or Pseudomonas aeruginosa among the yeast groups may be added / mixed in a proportion of 5 to 30 parts by weight based on the total weight of the mixed lactic acid bacteria.

For reference, side effects such as constipation appear depending on the constitution when the lactic acid bacteria are administered to the large intestine alone and overproduction. However, it is advantageous to prevent side effects such as constipation when mixed with lactic acid bacterium, such as Saccharomyces cerevisiae, Mycelia, and the like.

In case of female jealousy, lactic acid bacteria such as Lactobacillus rhamnosus GB-1 and Lactobacillus ruteri RC-14 can be mixed / prepared in the same ratio in the case of dryness, odor and perspiration.

Lactobacillus rhamnosus GB-1, which is a lactic acid bacterium, and Saccharomyces cerevisiae and Mycobacterium strains, which are yeast strains, can be mixed / prepared in the same proportions in the case of rhinitis, nasal clogging, dry nose and the like.

In addition, in the case of administration to the ear, it is possible to mix / prepare Sikaromyces cerevisiae and Lactobacillus ruteri RC-14 at a ratio of 9: 1 to otitis media.

In the case of eye administration, it is possible to prepare saccharomyces cerevisiae.

As described above, the dry benefit bacteria 10 designed and standardized for application to specific parts of the human body and specific diseases are 0.000001 to 80%, preferably 0.01 to 50%, more preferably 0.001 to 50% of the inner volume of the disposable syringe container 20 Is filled into the container portion 21 through the long pipe 22 through the inlet 23 of the syringe container, preferably 0.1 to 40%, more preferably 1 to 30%.

When the filling amount of the dry benefit bacteria 10 is excessively higher than the above range, dilution of the beneficial bacteria in the disposable container 20 can not be thoroughly diluted with moisture due to excessive filler of dry benefit bacteria, There is a problem that the diluted solution of the beneficial bacteria is forced out of the container 20 and is difficult to flow out. On the contrary, when the amount of the dry benefit bacteria 10 is less than the above range, the pharmacological effect is insufficient when administered into the body, there is a problem.

In the present invention, the disposable syringe container 20 is also referred to as a spoid or a pipette, as shown in FIG. 2, and is a tool for sucking up the solution, (22) are integrally formed.

The disposable eyedropper container 20 includes a container portion 21 having a predetermined space formed therein and capable of filling an object such as liquid or fine particles from the outside, a long pipe 22 formed integrally with the container portion, . Further, the function of the filler is made to flow out of the container portion 21 through the inlet 23 of the long pipe by the pressure of the hand of the hand applied to the outside of the container portion 21. [

In addition, the container portion 21 of the disposable syringe container 20 is formed of at least one material selected from the group consisting of elastic natural rubber, silicone rubber, latex rubber and synthetic rubber. The long tube 22 is made of glass, metal (Not shown) that is formed of at least one material selected from the group consisting of wood, plastic, and the like. The syringe 20 is commercially available.

As the disposable container, the inner area of the container portion 21 of the syringe container 20 may be sufficient to carry about 1 to 20 mL of packing material (dry benefit bacteria), and the long tube 22 of the syringe container may have a diameter of 0.1 to 6 mm And the length is preferably about 1 to 6 cm.

As the disposable container, the long tube 22 of the syringe container is easily inserted into at least one of nose, ear, anus, urethra, and female vagina in the body. In addition, the long tube 22 of the eyedropper container can be used as a diluent for the liquid-phase beneficial microorganism 10 produced by feeding water into the container portion 21 through the inlet 23 into the nose, ears, an urethra, urethra, Lt; RTI ID = 0.0 > and / or < / RTI >

The disposable syringe container 20 fills the dry beneficial bacteria 10 into the container.

Then, the container 20 filled with the dry beneficial bacteria 10 seals the inlet 23 of the container.

The method of sealing the container 20 filled with the dry beneficial bacteria 10 is such that the inlet 23 of the container is thermocompression-bonded to the container 23 with the thermal bonding machine in the case of the syringe 20 made of resin, The disposable syringe container 100 filled with dry benefit bacteria in which the container 20 is sealed inside as shown in Fig.

In addition, the method of sealing the inlet of the container 20 can be applied differently depending on the shape and material of the syringe container 20. For example, when the material of the inlet of the disposable syringe container 20 is any one of resin, glass, and plastic, which is made of rubber, wood, resin or the like, It is only necessary to seal the disposable container 20 by inserting it into the inlet 23.

In addition, a disposable syringe container having a generally short tube, such as a resin container made of resin commercially available on the market, is molded so that the inlet of the container can be fastened to the lid. A disposable syringe container (not shown) (Not shown) may be fastened to the inlet 23 to seal the disposable container 20.

By sealing the mouth of the disposable eyedropper container 20 after filling the inside of the disinfected bacterium 10 with the dry benefit bacterium 10 as described above, it is possible to prevent the outside air and moisture from contacting with the dry benefit- And thus the activity of the dry, beneficial microorganism (10) is inhibited and can be safely stored for a long period of time.

Further, the disposable syringe container 20 is provided with an inert gas of the Korean Patent Registration No. 100488472 in order to more safely prevent the bacteria from being activated by the air remaining in the container of the dry benefit bacteria 10 in the container 20 It is more preferable to add at least one selected from the group consisting of helium gas, argon gas, nitrogen gas and carbon dioxide as air-activated gas by replacing air with air as in the description of food packages used.

The disposable syringe 20 may be filled with the dry beneficial bacteria 10 so that the interior of the container 20 is in a vacuum state and the mixed gas containing nitrogen and carbon dioxide in a ratio of 7: , And then the container inlet is sealed to complete the sealing.

As described above, the operation of the disposable container 100 filled with the dry benefit bacteria of the present invention as described above is performed by cutting the sealing portion 24 of the syringe container using a tool such as a knife or scissors to open and close the container 20 3, the container portion 21 of the disposable syringe container is held by the handler, and then the mouth 23 of the syringe container long tube is inserted into the ear with the ear of the body, The operation is performed in which the dry, beneficial bacteria in the form of fine particles filled in the disposable syringe container are administered to the ear.

In addition, the operation of the disposable container 100 filled with the dry benefit bacteria of the present invention is performed by cutting the sealing portion 24 of the syringe container using a tool such as a knife or scissors to open and close the container 20, And then the mouth 23 of the syringe container is immersed in the water such as purified water and beverages and then repeatedly externally applied to the syringe container unit 21 to remove moisture Is introduced into the container portion (21) through the inlet (23) of the syringe container, and the dry benefit bacteria (10) is diluted with water to produce a dilute beneficial liquid in liquid form.

Next, the long tube 22 of the syringe container is inserted into the nose of the nose, the ear, the anus, the urethra and the vagina of the woman (preferably, (A method of squeezing by hand) applied to the hand of the handler outside the container portion 21 of the eyedropper, the eyedropper is inserted into the region of the eyelid, the anus, the urethra, The dilution liquid 10 of the beneficial bacteria in the container 20 is administered.

In this process, there is no pain at the site of administration, especially during the administration of anal, and it is advantageous that it can be easily administered without feces on the hands of the handler.

For reference, when the beneficial bacteria (10) diluted in water in the container (20) is visually administered, the disposable syringe container (100) carrying the beneficial microbial diluent is carefully contacted with the eyes It should be approached and administered indirectly.

Example 2.

4 is a perspective view illustrating a disposable syringe container filled with dry benefit bacteria according to an embodiment of the present invention. FIG. 5 is a cross- 4 is a perspective view illustrating the appearance of the disposable syringe container according to the first embodiment of the present invention, and FIG. 6 is a photograph schematically showing an operation state for explaining the operation of FIG.

First, as shown in Fig. 4 and Fig. 5, the dry, The packaged disposable syringe container 100 includes at least one dry benefit bacteria 10 selected from the group consisting of yeast and lactic acid bacteria and a disposable syringe container 30 sealed after the dry benefit bacteria are filled therein, 10 is packed with 0.000001 to 80% of the inner volume of the disposable syringe container 30, and the disposable syringe container 30 filled with the dry benefit bacteria is sealed so as to prevent contact with outside air and moisture Thereby inhibiting the activity of the beneficial microorganism, thereby enabling the dry beneficial microorganism to be safely stored for a long period of time.

As the disposable container according to the present invention, as shown in Figs. 4 and 5, the syringe container 30 is mainly used when administering medicines or liquids into the body, or when collecting blood, The syringe barrel 32 is formed integrally with the syringe barrel main body 31 and protrudes from the syringe barrel main body 31 and an inlet 33 formed in the syringe barrel is formed, A syringe bar 34 having fluidity and a rubber packing 35 inserted into the syringe barrel main body 31 and coupled to the plunger and a syringe barrel main body 31 And a space portion 36 formed between the rubber packing 35 and the syringe long pipe 32 in the interior of the space portion 36. The space portion 36 can fill the dry beneficial bacteria 10 from the outside, Also, (Dry and beneficial bacteria) 10 flows out of the container through the inlet 33 by the hand of a hand applied to the plunger 34 by the pressure.

As the disposable container, the long tube 32 of the syringe container is easily inserted into at least one of the eyes, nose, ears, anus, urethra, and vagina of the body, so that the eyes, nose, ears, And / or < / RTI >

In addition, the inlet 33 of the syringe container can dilute the beneficial bacteria 10 and diluent by supplying water into the container.

As the disposable container, the area of the space portion 36 of the syringe container 30 may be sufficient to carry about 1 to 20 mL of packing material (dry, beneficial bacteria).

The dried beneficial bacteria 10 filling the space 36 in the disposable syringe container 30 is the same as that of the first embodiment and the dry beneficial bacteria 10 is injected into the syringe container through the inlet 33 of the long tube It can be filled.

The method of filling the disinfecting bacteria 10 in the disposable syringe container 30 is not particularly limited. However, when the long tube 32 of the syringe container is brought into the microbial form of the dry benefit bacteria 10, The dry beneficial bacteria 10 in the form of fine particles can be introduced into the space portion 36 through the inlet 33 and filled therein.

At this time, the filling amount of the dry benefit bacteria 10 is 0.000001 to 80% of the inner volume of the disposable syringe container 30.

When filling is completed, the container 30 is sealed by inserting the cap 38 into the inlet 33 of the disposable syringe container 30.

Thus, the disinfecting syringe container 30 is blocked from contacting with the air and moisture outside the dry hummingbird 10, which is a filler, so that the dry humming microbicide 10 is inhibited from its activity and can be safely stored for a long period of time .

The operation of the disposable syringe container 100 filled with the dry benefit bacteria of the present invention as described above will be described below.

First, the cap 38 of the syringe container 30 is pulled by hand to open and close the syringe container 30. Then, after inserting the long tube 32 of the disposable syringe container into the diluent and pulling the plunger 34 by hand, The diluent is diluted with the dry benefit bacteria 10 through the dilution agent 33 into the space 36 inside the container by a necessary amount to prepare a dilute solution of the liquid phase.

Herein, the diluent is at least one selected from the group consisting of purified water, tap water, ionized water, alkaline water, deep ocean water, active water, ground water, mineral water, mineral water, mineral water and beverage.

Examples of the drink include yogurts, milk, carbonated drinks, ionic drinks, and the like.

6, when the long tube 32 of the disposable syringe container is inserted into the nose of the body and then pushed into the barrel 34 of the syringe by hand, the long barrel 32 of the disposable syringe barrel The diluted solution of beneficial bacteria in the container is injected into the nostril through the long tube 32 and the inlet 33 of the syringe container.

Of course, the disposable syringe container 100 filled with the dry benefit bacteria of the present invention can be easily administered to any part of the anus, urinary tract, or female vagina in the body, rather than the nose of the body.

In particular, the disposable syringe container 100 filled with dry beneficial bacteria does not cause pain during anal administration and is hygienic because it can be applied without any feces on the hands of the handler.

As described above, the disposable container 100 filled with the dry benefit bacteria of the present invention described above can be used for the treatment of beneficial bacteria at any one or more of the eyes, nose, anus, urethra, It has an epoch-making characteristic that an individual can easily and easily administer the composition to any one or more of the eyes, nose, anus, urethra and female vagina in the body.

In addition, the present invention is designed to standardize the beneficial bacteria to be packed in the disposable containers (20, 30) so that they can be manufactured in large quantities so as to be easily applied to specific diseases and specific sites in the body, Which can contribute to expansion of the beneficial bacteria field which is applied to at least one part of eyes, nose, anus, urethra and female quality in the body in order to promote health of human (including animal) It is an invention.

While specific embodiments of disposable containers filled with dry benefit bacteria belonging to the present invention as described hereinabove herein have been illustrated and described hereinabove, it should be understood that the invention is not limited by the foregoing embodiments, It will be understood by those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the present invention as defined by the appended claims, .

10: dry,
20: disposable syringe container 21: container of disposable syringe
22: long tube of disposable syringe 23: inlet of disposable syringe
24: Sealing part of disposable eyedropper inlet
30: Disposable syringe container 31: Disposable syringe container body
32: Disposable syringe container Long tube 33: Entrance of disposable syringe container
34: Push rod of disposable syringe container
35: Rubber packing attached to the plunger of the disposable syringe container
36: space portion of disposable syringe container 38: plug of disposable syringe container
A: Ears in the body B: Nose in the body
100: disposable container filled with dry beneficial bacteria

Claims (5)

And at least one disposable container selected from the group consisting of a syringe container and a syringe container, the at least one disposable container containing at least one dry benefit protein selected from the group consisting of yeast, lactic acid bacteria, 0.000001 ~ 80% of the volume is filled. The disposable container filled with dry benefit bacteria seals the inlet so as to prevent contact with outside air and moisture, thereby inhibiting the activity of the beneficial bacteria. Thus, the dry beneficial bacteria can be stored safely for a long period of time Wherein the container is filled with dry benefit bacteria. The method according to claim 1,
The yeast may be selected from the group consisting of Shikaromisu serebicia, Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp., Candida spp. Corynebacterium, Cryptobacillus, Candida albicans, Cryptobacillus, Cryptobacillus, Cryptobacillus, Cryptobacterium, Cryptobacillus, Cryptobacillus, Cryptobacillus, Corn cobs, corn cobs, corn cobs, corn cobs, corn cobs, corn cobs, corn cobs, bovine yeast group. The method according to claim 1,
The lactic acid bacteria may be selected from the group consisting of Lactobacillus ashidophilus, Lactobacillus casei, Lactobacillus sake lactobacillus sake lactobacillus bulgaricus, Lactobacillus fermantum, Lactobacillus fulantarum, Lactobacillus lambosus, Lactobacillus salivarius, Lactobacillus breve , Lactobacillus helveticus, Lactobacillus ruteri, Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium animarlis lactis, Streptococcus mutans Disposable container filled with at least one dry beneficial bacteria selected from the group consisting of Pellucose and Weissella corinisis. The method according to claim 1,
Wherein the dry beneficial bacteria are added with 0.00001-50 parts by weight of at least one member selected from the group consisting of nutrients, herbal medicine extracts, powdered milk, sugar, starch, and flour, based on the total weight of the beneficial bacteria. The method according to claim 1,
The disposable container is a micro active gas containing at least one selected from the group consisting of helium gas, argon gas, nitrogen gas and carbon dioxide as air activated to prevent the bacteria from being activated by air remaining in the container of dry benefit bacteria in the container. Lt; RTI ID = 0.0 > Filled disposable containers.

Images